Reforming Prostate Cancer Testing: Chris Hoy’s Urgent Appeal for Change Olympic cyclist Sir Chris Hoy is urging better prostate cancer testing after his terminal diagnosis revealed gaps in the NHS, especially for men under 50 and high-risk groups. According to Cancer Research UK, current PSA testing is limited, and they are advocating for better early detection methods. RMDM’s PanTum Detect, is a blood test that identifies multiple cancers early, could fill these gaps, improving survival rates and patient care through timely intervention. Dr Michelle Roberts Ali Ghaidan Johannes Coy Letizia Gulino Royal College of Physicians NHS NICE - National Institute for Health and Care Excellence The Cancer Screening Trust Mike Farrar Cancer Research UK (CRUK) #earlydetection #cancerscreening #nhs #sirchrishoy #preventionisbetterthancare #cancer #diagnostics https://lnkd.in/gUYKtGXZ
RMDM Limited
Medical Equipment Manufacturing
London, England 422 followers
The one-stop shop for healthier living and disease prevention. Changing the way we view and treat cancer.
About us
RMDM Group was set up in 2017 and is founded on the principles of the pioneering work of Dr Johannes Coy. Inspired by the Latin remedērī, literally meaning ‘to heal again’, RMDM Group harnesses the power of cutting-edge research and technology to provide practical and affordable Remedies. The Remedies are centred around Diagnostics and Metabolic solutions for people proactively looking to live healthier lives. We build value for our stakeholders through our impeccable research credentials and the delivery of dynamic diagnostic and nutraceutical Innovations that positively disrupt the health/wellbeing industry.
- Website
-
https://rmdm.group
External link for RMDM Limited
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
Locations
-
Primary
1 Knightsbridge Green
London, England SW1X 7QA, GB
Employees at RMDM Limited
Updates
-
RMDM Limited reposted this
Elevate your low-carb baking with Dr. Coy’s gluten-free flour mixture! Made with almond flour, coconut flour, resistant dextrin, and konjac flour, it helps keep blood sugar stable, supports satiety, and lowers calorie density. Perfect for all your low-carb recipes! Check out our recipes on our Instagram page and website for inspiration. https://lnkd.in/eKPRRDg8 🍰🧁👨🏼🍳👩🏻🍳 #LowCarbLifestyle #HealthyBaking #GlutenFree #BloodSugarFriendly #HealthyEating #LowGI #DrCoys #keto #ketofriendly #ketobaking #diabetes #diabeticfriendly #healthynutrition #nutrition #lowcarbbaking Ali Ghaidan RMDM Limited Johannes Coy Letizia Gulino Jonas Schöneberg GesundheitsManufaktur NuPrevento TAVARLIN Dr. Coy's Health Foods Ltd. Max della Torre E Tasso Mariam RG
-
Government and Tech Innovators Unite to Advance Cancer Detection: The Potential of Pantum Detect A recent press release has outlined the UK government's plans to boost tech deals with the aim to at further innovate cancer diagnosis in the country. This initiative follows the Darzi review, which highlighted the urgent need to improve cancer survival rates within the NHS. Technological innovation is necessary for improved diagnostic procedures. Our Pantum Detect blood test is a universal, cost-efficient, non-invasive solution. Mike Farrar NHS Royal College of Physicians SAMRA TURAJLIC Cancer Research UK (CRUK) Johannes Coy Ali Ghaidan The Francis Crick Institute Public Health England The Royal Marsden NHS Foundation Trust #earlydetection #cancerdetection #cancer #screening #nhs #healthtech #medtech #TKTL1 #preventionbetterthancure #specificity #sensitivity https://lnkd.in/ecv2jiEm
Government and Tech Innovators Unite to Advance Cancer Detection: The Potential of Pantum Detect
https://rmdm.group
-
RMDM Limited reposted this
Can sugar really switch on fat-burning? 🔥 Yes, but it’s all about the right sugar. Like galactose – a natural sugar found in dairy products such as yogurt and kefir. Unlike classic sugar, galactose helps burn fat even as you eat! It ‘forces’ your cells to use fat and oxygen for fuel, supporting a healthier metabolism. The taste is similar, but your body responds in a whole new way. 🌿 Check out our website for more information💡 https://lnkd.in/eK3PxW-4 #Galactose #FatBurning #NaturalSugar #HealthyLiving #MetabolismBoost #WeightManagement #HealthyChoices #Nutrition #WellnessJourney #DairyBenefits #metabolism #sugar #bloodsugar #bloodglucose #diabetes Ali Ghaidan RMDM Limited Letizia Gulino Johannes Coy Jonas Schöneberg GesundheitsManufaktur NuPrevento TAVARLIN Dr. Coy's Health Foods Ltd. Max della Torre E Tasso Mariam RG
-
The Darzi Report Findings: The Urgent Need for Innovative Technology in NHS Cancer Care With the NHS facing critical challenges in cancer diagnosis and care, including delays and rising mortality rates, the launch of our PanTum Detect® early detection test offers a transformative solution. As highlighted in the recent Darzi report, integrating such advanced technology is essential for overcoming the NHS’s current struggles and advancing cancer care. Mike Farrar Letizia Gulino Ali Ghaidan Johannes Coy NHS Royal College of Physicians Public Health England Ministry of Health Saudi Arabia Public Health Authority of Saudi Arabia Ministry of Health and Prevention - UAE Professor the Lord Darzi of Denham OM KBE PC FRS #earlydetection #cancer #preventionbetterthancure #costefficiency #cancerresearch #cancertreatment #cancercare #cancerawareness #nhs https://lnkd.in/eupd4xKT
Darzi Report Findings: The Urgent Need for Innovative Technology in NHS Cancer Care
https://rmdm.group
-
RMDM Group is the one-stop-shop healthcare solution provider, primarily focused on oncology, for anyone wanting to improve their health and wellbeing. Linking traditional medicine with pioneering diagnostics and revolutionary nutritional products, our work helps people make healthier everyday choices and makes disease prevention and management accessible and simple for all. #metabolism #earlydetectionsaveslives #preventionisbetterthancure #accuracymatters #cancer #rmdm #PanTumDetect #nhs #cancermetabolism #TKTL1 #CoyPrinicple Ali Ghaidan Letizia Gulino Johannes Coy Mike Farrar Max della Torre E Tasso
RMDM Diagnostics - An Introduction
https://www.youtube.com/
-
Last month, the UK National Screening Committee highlighted the need for a multi-cancer detection test in the UK. At RMDM, we are actively working with research and medical institutions to showcase how our technology can help offer a solution. To date, PanTum Detect has been tested using more than 160,000 samples and found to be effective across over 50 cancer tumour types, which together represent the majority of all cancer cases - and it is already commercially available. Read our latest article to find out more about the roadmap the UK National Screening Committee is putting in place, and how PanTum Detect can bridge the gap in cancer detection. https://lnkd.in/eiWt4rUA Ali Ghaidan Johannes Coy Letizia Gulino Mike Farrar Cancer Research UK (CRUK) Tom Callender Public Health England NHS England Dubai Health Authority Ministry of Health and Prevention - UAE Ministry of National Guard Health Affairs (MNGHA) Royal College of Physicians
The UK’s Approach to Multi-Cancer Detection Tests
https://rmdm.group
-
2024 Edition of Pantum Detect Whitepaper We've recently launched an updated edition of our PanTum Detect whitepaper. This 2024 edition highlights groundbreaking findings in liquid biopsy and multi-cancer detection, demonstrating the immense potential of the PanTum Detect test to transform early cancer screening programs. “To date, PanTum Detect has been tested using more than 160,000 samples and found to be effective across 50 cancer tumour types, which together represent the majority of all cancer cases. Rather than focusing on multiple single-cancer screening tests, a universal test can improve the overall effectiveness of early screening programs.” Dive into the comprehensive analysis and see how PanTum Detect can provide a first point of information that will help save more lives and meet cancer targets in the UK and worldwide. Read it here: https://lnkd.in/ey64y5Ad #cancer #earlycancerdetection #rmdm #pantumdetect #preventionisbetterthancure #whitepaper #multicancerdetection #earlydetection #cancerscreening #earlycancerscreening
-
RMDM Limited reposted this
🩺📊 Recent Study Highlights Prediabetes and Cancer Risks People with prediabetes face an 11-25% higher risk of developing cancer compared to the general population. For liver cancer, the risk jumps to 23-44%, and for all liver tumours, including bile duct cancers, the risk can be up to 101% higher. Prediabetes also increases the risk of dementia by 18-47%, cardiovascular disease by 20-30%, and overall mortality by 8-25%. Replacing classic sugars with Dr. Coy’s sugars, such as galactose and tagatose, could help avoid these risks. Research shows that galactose causes a slower rise in blood sugar compared to classic sugars. Diabetes experts strongly recommend tagatose for nutritional diabetes treatment, and the European Food Standards Agency (EFSA) confirms that drinks with tagatose induce a lower blood glucose rise than those with classic sugar. Find out more about Dr. Coy's Sugars on our website🌟🍭 #Prediabetes #HealthRisks #DrCoys #Galactose #Tagatose #HealthyLiving #DiabetesManagement #Nutrition Ali Ghaidan RMDM Limited Johannes Coy Jonas Schöneberg GesundheitsManufaktur NuPrevento TAVARLIN Dr. Coy's Health Foods Ltd. Max della Torre E Tasso Mariam RG
-
Traditional cancer screenings often detect diseases too late. New multi-cancer early detection tests (MCEDs) are changing this by using innovative biomarkers to identify cancers early through minimally invasive methods like blood samples. There is a substantial demand for multi-cancer early detection tests given the potential to significantly improve survival rates and treatment outcome. PanTum Detect stands out as an MCED test, detecting tumours with 95.21% sensitivity and 99.53% specificity across 50+ cancer types. Now available in multiple countries, it enhances early screening programs by combining blood tests with advanced imaging. RMDM's collaboration with the Doctors Center Polyclinic in Dubai extends PanTum Detect to the MENA region, offering comprehensive early cancer detection and peace of mind. Read more about the future of MCEDs and PanTum Detect: https://lnkd.in/evhfyKZE Ali Ghaidan Johannes Coy Letizia Gulino Cancer Research UK (CRUK) Middle East Journal of Cancer Ministry of Health and Prevention - UAE Khodr ISSA, PhD #CancerDetection #EarlyScreening #HealthcareInnovation #PanTumDetect #MCED
Why Multi-Cancer Early Detection Tests are the Future
https://rmdm.group